Pathogenic vs Risk Variants: Understanding the Difference

The most important distinction in genetic testing

When you get a genetic health report, you'll see variants classified in different ways. The single most important thing to understand is the difference between two categories:

• Pathogenic variants — specific mutations known to cause or strongly predispose to disease. These are well-studied, clinically validated, and often actionable.
• Risk factor variants — common SNPs associated with a slightly increased or decreased statistical risk for complex conditions. These are population-level observations, not individual predictions.

These two types of findings require completely different responses. A pathogenic BRCA1 variant might mean you need increased cancer screening. A risk factor variant associated with 1.15x risk for type 2 diabetes is interesting context but doesn't change what you should do tomorrow.

Pathogenic variants: what they are and what to do

A pathogenic variant is a specific change in a gene that is known to cause disease or significantly increase disease risk. These classifications come from clinical laboratories and expert panels who have reviewed substantial evidence.

Examples of pathogenic variants

• BRCA1/BRCA2 — pathogenic variants in these tumor suppressor genes significantly increase lifetime risk of breast cancer (to 45-72%) and ovarian cancer. These are among the most well-known and most actionable genetic findings.
• CFTR — pathogenic variants cause cystic fibrosis (when two copies are inherited) or carrier status (one copy).
• HFE C282Y — homozygous pathogenic variant causes hereditary hemochromatosis (iron overload).
• Factor V Leiden — increases risk of blood clots, especially in combination with hormonal contraceptives or surgery.

What to do with a pathogenic finding

1. Check the inheritance pattern. Is the condition dominant (one copy enough) or recessive (need two copies)?
2. Check your zygosity. Are you homozygous (two copies) or heterozygous (one copy)?
3. Dominant + any copies = potentially affected. Talk to your doctor.
4. Recessive + heterozygous = carrier. You're likely healthy. Relevant for family planning (see our carrier status guide).
5. Recessive + homozygous = potentially affected. Talk to your doctor.
6. Consider clinical confirmation. Consumer DNA tests are screening tools. For pathogenic findings that affect medical decisions, clinical-grade confirmatory testing is recommended.

Risk factor variants: what they are and why not to panic

Risk factor variants are common genetic variations found across the population that are statistically associated with slight changes in disease risk. They're identified through genome-wide association studies (GWAS) that compare thousands of people with a condition to thousands without it.

How to read risk numbers

When a report says a variant gives you "1.3x risk" for a condition, here's what that actually means:

• If the general population risk is 10%, your risk is about 13%.
• If the general population risk is 1%, your risk is about 1.3%.

The base rate matters enormously. A 1.3x increase for a rare condition is barely noticeable. The same multiplier for a common condition is more meaningful, but still modest.

Why single risk variants are rarely actionable

Most complex diseases (diabetes, heart disease, Alzheimer's, most cancers) are influenced by hundreds or thousands of genetic variants, each contributing a tiny amount of risk, plus major environmental and lifestyle factors. Having one or even several risk-increasing variants doesn't change the fundamentals: eat well, exercise, don't smoke, manage stress, get regular checkups.

When risk variants do matter

Some risk variants have larger effects and are more actionable:

• APOE e4 — the most significant common risk variant for Alzheimer's disease. One copy increases risk roughly 3x, two copies roughly 12x. This is worth knowing about for lifestyle and prevention planning, though there's no guaranteed prevention.
• TCF7L2 — one of the stronger risk variants for type 2 diabetes. Homozygous carriers have roughly 2x risk, which is meaningful enough to inform diet and exercise motivation.

The ClinVar classification system

ClinVar is a public database maintained by the NCBI (part of the NIH). It collects variant classifications from clinical laboratories worldwide. Understanding ClinVar classifications helps you interpret your results:

• Pathogenic — strong evidence that this variant causes disease.
• Likely pathogenic — high probability of causing disease, but slightly less evidence. Treated clinically the same as pathogenic.
• Uncertain significance (VUS) — not enough evidence to classify. This is NOT a positive finding — it means "we don't know yet." Don't make medical decisions based on VUS.
• Likely benign — probably harmless.
• Benign — definitely harmless. A normal variation.

ClinVar star ratings

Each ClinVar classification also has a confidence rating from 0 to 4 stars:

• 4 stars — reviewed by expert panel or practice guideline. Highest confidence.
• 3 stars — reviewed by multiple clinical labs with no conflicts. Very reliable.
• 2 stars — multiple submitters with some disagreement, or single submitter with well-documented criteria.
• 1 star — single submitter with some criteria provided.
• 0 stars — no assertion criteria provided. Take with a grain of salt.

Focus your attention on higher-star classifications. A 4-star pathogenic variant is well-established. A 0-star classification from a single lab may be revised later.

How to read your disease risk report without panicking

1. Start with pathogenic/likely pathogenic findings. These matter most. Check inheritance pattern and zygosity.
2. Check the star rating. Higher stars = more confidence.
3. Separate carrier status from affected status. Heterozygous for a recessive condition = carrier (you're fine). Homozygous or dominant = potentially affected.
4. Then look at risk factors. Note them for context, but don't change your life based on a 1.1x risk increase.
5. Ignore VUS for now. "Uncertain significance" means the scientific community hasn't figured it out yet. Check back in a year — some VUS get reclassified.

Penetrance: why having a variant doesn't guarantee disease

Penetrance refers to the percentage of people with a pathogenic variant who actually develop the associated condition. It's rarely 100%.

• High penetrance — most people with the variant develop the condition (e.g., Huntington's disease is nearly 100% penetrant).
• Moderate penetrance — a significant portion but not all (e.g., BRCA1 pathogenic variants have roughly 45-72% penetrance for breast cancer by age 80).
• Low penetrance — only a small percentage develop the condition.

Penetrance can also vary by sex, age, environment, and other genetic factors. This is why a pathogenic variant doesn't automatically mean you'll get the disease.

Why false positives happen

Consumer DNA tests occasionally produce false positive findings, especially for:

• Insertions and deletions (indels) — consumer genotyping arrays aren't designed to detect these accurately. A "pathogenic" finding involving an insertion or deletion may be a technical artifact. Quality analysis pipelines filter these out.
• Rare variants on common chips — genotyping arrays are optimized for common variants. Rare variants may be miscalled.
• Strand orientation errors — sometimes the reference and alternate alleles get flipped during processing.

This is why clinical confirmation is recommended for any pathogenic finding that would change medical management.

Frequently asked questions

My report shows a pathogenic variant. Am I going to get sick?

Not necessarily. Check the inheritance pattern, your zygosity, and the penetrance. Then talk to a doctor or genetic counselor. Many pathogenic variants are for recessive conditions where being heterozygous just means carrier status.

What should I do about "uncertain significance" findings?

Generally nothing right now. VUS means the evidence isn't clear enough to classify. Don't make medical decisions based on them. Some services update classifications as ClinVar is updated, so these may be resolved over time.

Are risk factor variants worth knowing about?

They're useful context, especially when multiple risk variants point in the same direction. But individual risk variants with small effect sizes rarely change what you should be doing.

Should I get clinical testing to confirm consumer results?

For pathogenic findings that would affect medical decisions (like increased cancer screening or medication changes), yes. For risk factor variants and carrier status, clinical confirmation is less critical but can be pursued through a genetic counselor.